Ensysce Biosciences, Inc. (ENSC)

Trade Setup

Ensysce Biosciences, Inc., a clinical-stage biotech company, engages in developing various prescription drugs. The company is developing tamper-proof opioids using Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms. Its products treat severe pain and assist in preventing deaths caused by opioid abuse.

Stocks found in the category TradersPro New Uptrend are low priced stocks priced between .20 and $7, with at least 50k shares of average shares trading per day.   The stocks are starting new uptrends and have buy signals.  These are high reward to risk stocks with the potential for very sharp moves.  A stop should be maintained at the low of the most recent hold signal day.   Target prices for exits can be determined by using the next level of resistance higher or by using Fibonacci resistance levels found using TradersPro. Trailing stops or letting the stock run until the next sell signal is also a sell strategy.

X